Get Ready, Trader!
We played Guided Therapeutics Inc. (GTHP) for a sweet 50% two-day run before the correction. I want to arrive at the next party even EARLIER.
The story here is still cancer tests. GTHP sells enough diagnostic kits in places like Bangladesh and Turkey to unlock 7 figures in a single headline.
That sales stream hasn’t changed! But it’s been a rough patch for the market and now GTHP is uncannily back to where it was before the rally:

Eagle eyed Posse recruits ought to note TWO things. First, GTHP is flashing “oversold” again on the RSI just like it did in August when we came in.
Similar bottom-building behavior, more or less respecting $0.04 as the base. Somewhat BETTER volume trend as the selling bars drop day by day.
Detail Number 2 is of course that August oversold rally we grabbed. We were actually a little late to the party, coming in around $0.057.
This time I don’t want to be late! I want to be EARLY. If we’d started our last GTHP party at the turn, we could have scored 3 digits EASY!
So I’m thinking that if GTHP is set up to mirror that previous bounce next week, it don’t hurt much to get it on the radar in the here and now.
The rest of the market might start putting the GTHP pieces together tomorrow, Monday, whenever. They snooze, they lose! You get FIRST shot.
Now I know you Uncle Junior types forgot what GTHP does. No shame in that. Let me refresh your memory!
The Commander’s Bullet Points on GTHP
-
Shining the light on pre-cancer seems to do the trick, though. It’s cost-effective for countries like Turkey and Nigeria and Bangladesh, while if my math is right GTHP racks up $20,000 per scanner.
Bottom Line: I’ll drone on about the fundamentals and the news flow tomorrow morning, but right now the big opportunity is catching the bounce.
Go back to that chart. If you think GTHP is set up spookily like it was before the correction threw all the charts off course, you know what to do.
We were late to the game last time around and still did really, really well. Here, the band is still tuning up for their first big number.
I’m not seeing a whole lot of implied “resistance” between this $0.04 platform and the 50-day trend line, either. The technical sky is open!
All GTHP really needs is a bump from the headlines. Something from Turkey or one of the countries they work with. Something from the FDA.
It only took a nudge last time to get that 3-digit run rolling. When the next one happens, I want your head in THIS game!
Happy, Happy, Happy Trading!
~ Stock Commander
yourstockcommander@gmail.com